Illumina Inc
ILMN
NASDAQ. Currency in USD
191.59 -7.95 ( -3.98% )
Market Cap.
30.14B
Beta (5Y monthly)
1.13
Price/Earnings
77.08
EPS (TTM)
2.73
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
1.20M
1y Target Est.
249.11
Day's Range
52 Week's Range
Historical Summary
Performance
1 Month
-13.13%
YTD
-49.64%
1Y
-50.23%
2Y
-47.66%
-27.67% ann.
3Y
-41.09%
-16.17% ann.
5Y
-10.78%
-2.26% ann.
10Y
267.27%
13.90% ann.
EPS growth
1Y
-57.54%
2Y
-45.18%
25.98% ann.
3Y
-55.97%
23.92% ann.
5Y
-20.18%
4.41% ann.
10Y
93.62%
6.83% ann.
20Y
610.28%
10.30% ann.
Share Buybacks
3 Months
-0.00%
6 Months
1.26%
1Y
-2.61%
2Y
-6.08%
3Y
-6.08%
5Y
-6.08%
10Y
-18.48%
20Y
-152.65%
About Illumina Inc
Sector
Healthcare
Industry
Diagnostics & Research
Website
https://www.illumina.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
156.30M
Employees
9800
Address
5200 Illumina Way, San Diego, CA, United States, 92122
Latest news

Is Illumina Cheap or Expensive?
It depends on which numbers you focus on.
By The Motley Fool - 7 weeks ago
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
Upgrades
For Colliers International Group Inc (NASDAQ:CIGI), Goldman Sachs upgraded the previous rating of Neutral...
By Benzinga - 7 weeks ago

Tracking Al Gore's Generation Investment Management Portfolio - Q3 2022 Update
Al Gore's 13F portfolio value decreased from $18.35B to $16.86B this quarter. Find out Generation...
By Seeking Alpha - 8 weeks ago

Amazon To $103? Plus Piper Sandler Predicts $300 For Illumina
Rosenblatt boosted the price target on Amazon.com, Inc. (NASDAQ: AMZN) from $118 to $103. Rosenblatt...
By Benzinga - 11 weeks ago

What 12 Analyst Ratings Have To Say About Illumina
Within the last quarter, Illumina (NASDAQ:ILMN) has observed the following analyst ratings:
Bullish
Somewhat Bullish...
By Benzinga - 12 weeks ago

11 Analysts Have This to Say About Illumina
Within the last quarter, Illumina (NASDAQ:ILMN) has observed the following analyst ratings:
Bullish
Somewhat Bullish...
By Benzinga - 13 weeks ago

Illumina (ILMN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Illumina (ILMN) possesses the right combination of the two key ingredients for a likely earnings...
By Zacks Investment Research - 14 weeks ago

Wall Street Is Still Bullish on This Punished Growth Stock -- Is It a Buy?
Bionano's stock price movements have little to do with its successes.
By The Motley Fool - 14 weeks ago